{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:40:45Z","timestamp":1790667645579,"version":"4.1.0"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Antwerp University Valorisation Funds","award":["48068"],"award-info":[{"award-number":["48068"]}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G031222N"],"award-info":[{"award-number":["G031222N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["W001620N"],"award-info":[{"award-number":["W001620N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G082525N"],"award-info":[{"award-number":["G082525N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The intestinal mucosal barrier plays an important role in the pathophysiology of inflammatory bowel disease (IBD), with mucins being key components of this barrier. Classified as either transmembrane or secreted, these highly glycosylated proteins protect the mucosal barrier while also influencing barrier integrity. Given their indispensable role in maintaining the intestinal mucosal barrier, mucins are compelling candidates for the evaluation of barrier dysfunction. Numerous studies have investigated mucins in the context of IBD, but a clear consensus regarding their expression, polymorphisms, and post-translational modifications is missing. This systematic review summarizes mucin alterations at the transcriptional, translational, and post-translational levels in the presence\/absence of intestinal inflammation in IBD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To this end, PubMed, Scopus, and Web of Science were searched for studies published between February 1993 and January 2025, yielding 69 articles eligible for inclusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of MUC1, MUC5AC, and MUC6 was reported to be upregulated at both RNA (isoform) and protein level, in contrast to MUC12, which exhibited reduced expression in inflamed mucosa only at RNA isoform level. MUC2 was the only mucin consistently downregulated at the protein level, despite unchanged mRNA expression, whereas polymorphisms of MUC2, MUC3A, MUC4, MUC13, MUC19, MUC21, and MUC22 were associated with susceptibility to Crohn\u2019s disease, ulcerative colitis, or IBD in general. Post-translational modifications, such as hypoglycosylation of MUC1 and MUC2, as well as a reduction of mucin sulphation of MUC2 were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Together, these findings underscore the involvement of mucins in IBD and point to their potential as biomarkers for barrier dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izaf293","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:17:57Z","timestamp":1764001077000},"page":"375-389","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-2861","authenticated-orcid":false,"given":"Wout","family":"Arras","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Infla-Med, Centre of Excellence, University of Antwerp , Antwerp,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-9315","authenticated-orcid":false,"given":"Baptiste","family":"Oosterlinck","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Infla-Med, Centre of Excellence, University of Antwerp , Antwerp,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9533-2535","authenticated-orcid":false,"given":"Julie","family":"Gassman","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Infla-Med, Centre of Excellence, University of Antwerp , Antwerp,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-7693","authenticated-orcid":false,"given":"Joris G","family":"De Man","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Infla-Med, Centre of Excellence, University of Antwerp , Antwerp,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-8692","authenticated-orcid":false,"given":"Aranzazu","family":"Jauregui-Amezaga","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Division of Gastroenterology and Hepatology, Antwerp University Hospital , Edegem,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0327-6304","authenticated-orcid":false,"given":"Benedicte Y","family":"De Winter","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Infla-Med, Centre of Excellence, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Division of Gastroenterology and Hepatology, Antwerp University Hospital , Edegem,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1271-6191","authenticated-orcid":false,"given":"Annemieke","family":"Smet","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp,","place":["Belgium"]},{"name":"Infla-Med, Centre of Excellence, University of Antwerp , Antwerp,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2026013010481755300_izaf293-B1","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"New Engl J Med"},{"key":"2026013010481755300_izaf293-B2","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1001\/jama.2013.4466","article-title":"Management of active Crohn disease","volume":"309","author":"Cheifetz","year":"2013","journal-title":"JAMA"},{"key":"2026013010481755300_izaf293-B3","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"Chang","year":"2020","journal-title":"New Engl J Med"},{"key":"2026013010481755300_izaf293-B4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the Prospective ERIca trial","volume":"164","author":"Rath","year":"2023","journal-title":"Gastroenterology"},{"key":"2026013010481755300_izaf293-B5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S2468-1253(21)00431-3","article-title":"The role of mucins in gastrointestinal barrier function during health and disease","volume":"7","author":"Breugelmans","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2026013010481755300_izaf293-B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026013010481755300_izaf293-B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41392-024-02043-4","article-title":"Mucosal immune response in biology, disease prevention and treatment","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct Target Ther."},{"key":"2026013010481755300_izaf293-B8","doi-asserted-by":"publisher","first-page":"jjae155","DOI":"10.1093\/ecco-jcc\/jjae155","article-title":"The intestinal mucin isoform landscape reveals region-specific biomarker panels for inflammatory bowel disease patient stratification","volume":"10","author":"Arras","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026013010481755300_izaf293-B9","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/mi.2015.32","article-title":"New developments in goblet cell mucus secretion and function","volume":"8","author":"Birchenough","year":"2015","journal-title":"Mucosal Immunol."},{"key":"2026013010481755300_izaf293-B10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0006-291X(05)80888-5","article-title":"Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit","volume":"173","author":"Lancaster","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2026013010481755300_izaf293-B11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/hmg\/8.2.307","article-title":"Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3","volume":"8","author":"Kyo","year":"1999","journal-title":"Hum Mol Genet."},{"key":"2026013010481755300_izaf293-B12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00109-006-0100-2","article-title":"Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease","volume":"84","author":"Moehle","year":"2006","journal-title":"J Mol Med (Berl)."},{"key":"2026013010481755300_izaf293-B13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s100380170118","article-title":"Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn\u2019s disease","volume":"46","author":"Kyo","year":"2001","journal-title":"J Hum Genet"},{"key":"2026013010481755300_izaf293-B14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000453594","article-title":"Transmembrane mucins: signaling receptors at the intersection of inflammation and cancer","volume":"9","author":"van Putten","year":"2017","journal-title":"J Innate Immun."},{"key":"2026013010481755300_izaf293-B15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/cells12091224","article-title":"IL-22-activated MUC13 impacts on colonic barrier function through JAK1\/STAT3, SNAI1\/ZEB1 and ROCK2\/MAPK signaling","volume":"12","author":"Breugelmans","year":"2023","journal-title":"Cells"},{"key":"2026013010481755300_izaf293-B16","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/ecco-jcc\/jjaa015","article-title":"In-depth study of transmembrane mucins in association with intestinal barrier dysfunction during the course of T cell transfer and DSS-induced colitis","volume":"14","author":"Breugelmans","year":"2020","journal-title":"J Crohns Colitis."},{"key":"2026013010481755300_izaf293-B17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","article-title":"Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease","volume":"4","author":"Martini","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026013010481755300_izaf293-B18","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"2026013010481755300_izaf293-B19","author":"Wells"},{"key":"2026013010481755300_izaf293-B20","doi-asserted-by":"publisher","first-page":"e0147601","DOI":"10.1371\/journal.pone.0147601","article-title":"Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis","volume":"11","author":"Modesti","year":"2016","journal-title":"PLoS One."},{"key":"2026013010481755300_izaf293-B21","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/gutjnl-2018-317571","article-title":"Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis","volume":"68","author":"van der Post","year":"2019","journal-title":"Gut"},{"key":"2026013010481755300_izaf293-B22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/ibd\/izaa064","article-title":"Muc5ac expression protects the colonic barrier in experimental colitis","volume":"26","author":"Olli","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12931-021-01920-8","article-title":"MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model","volume":"23","author":"Huang","year":"2022","journal-title":"Respir Res."},{"key":"2026013010481755300_izaf293-B24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jcmgh.2022.06.010","article-title":"MUC1-mediated macrophage activation promotes colitis-associated colorectal cancer via activating the interleukin-6\/signal transducer and activator of transcription 3 axis","volume":"14","author":"Sheng","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2026013010481755300_izaf293-B25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2011.12.036","article-title":"The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice","volume":"142","author":"Nishida","year":"2012","journal-title":"Gastroenterology"},{"key":"2026013010481755300_izaf293-B26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/j.gastro.2007.07.003","article-title":"Muc1 mucin limits both helicobacter pylori colonization of the murine gastric mucosa and associated gastritis","volume":"133","author":"McGuckin","year":"2007","journal-title":"Gastroenterology"},{"key":"2026013010481755300_izaf293-B27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/j.gastro.2006.09.006","article-title":"Cysteine-rich domains of Muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing","volume":"131","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"2026013010481755300_izaf293-B28","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1038\/onc.2015.327","article-title":"Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer","volume":"35","author":"Das","year":"2016","journal-title":"Oncogene"},{"key":"2026013010481755300_izaf293-B29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jcmgh.2023.08.011","article-title":"MUC13 cell surface mucin limits salmonella typhimurium infection by protecting the mucosal epithelial barrier","volume":"16","author":"McGuckin","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"2026013010481755300_izaf293-B30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13046-019-1279-8","article-title":"Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop","volume":"38","author":"Yang","year":"2019","journal-title":"J Exp Clin Cancer Res."},{"key":"2026013010481755300_izaf293-B31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4172\/2155-9899.1000257","article-title":"MUC18 differentially regulates pro-inflammatory and anti-viral responses in human airway epithelial cells","volume":"5","author":"Huang","year":"2014","journal-title":"J Clin Cell Immunol."},{"key":"2026013010481755300_izaf293-B32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1177\/44.10.8813081","article-title":"Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues","volume":"44","author":"Weiss","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"2026013010481755300_izaf293-B33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/bbrc.1996.1039","article-title":"Quantitative analysis of MUC2 synthesis in ulcerative colitis","volume":"224","author":"Tytgat","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"2026013010481755300_izaf293-B34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/gut.38.4.554","article-title":"MUC2 is the prominent colonic mucin expressed in ulcerative colitis","volume":"38","author":"Tytgat","year":"1996","journal-title":"Gut"},{"key":"2026013010481755300_izaf293-B35","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1097\/MIB.0000000000001246","article-title":"Genetic and transcriptomic bases of intestinal epithelial barrier dysfunction in inflammatory bowel disease","volume":"23","author":"Vancamelbeke","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"2026013010481755300_izaf293-B36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<304::AID-PATH375>3.0.CO;2-A","article-title":"Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn\u2019s disease increases detectability of the MUC2 protein core","volume":"188","author":"Hanski","year":"1999","journal-title":"J Pathol"},{"key":"2026013010481755300_izaf293-B37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diff.2008.09.008","article-title":"Differences in goblet cell differentiation between Crohn\u2019s disease and ulcerative colitis","volume":"77","author":"Gersemann","year":"2009","journal-title":"Differentiation"},{"key":"2026013010481755300_izaf293-B38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.crohns.2011.09.013","article-title":"Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD","volume":"6","author":"Gersemann","year":"2012","journal-title":"J Crohns Colitis"},{"key":"2026013010481755300_izaf293-B39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/ecco-jcc\/jjx139","article-title":"Transcriptomic landscape of treatment\u2014na\u00efve ulcerative colitis","volume":"12","author":"Taman","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2026013010481755300_izaf293-B40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ibd\/izac217","article-title":"Aberrant mucin expression profiles associate with pediatric inflammatory bowel disease presentation and activity","volume":"29","author":"Breugelmans","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/ph16020324","article-title":"Mucosal genes expression in inflammatory bowel disease patients: new insights","volume":"16","author":"Alarfaj","year":"2023","journal-title":"Pharmaceuticals"},{"key":"2026013010481755300_izaf293-B42","first-page":"193","article-title":"IL-8 and LYPD8 expression levels are associated with the inflammatory response in the colon of patients with ulcerative colitis","volume":"12","author":"Okada","year":"2020","journal-title":"Biomed Rep"},{"key":"2026013010481755300_izaf293-B43","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1038\/srep07343","article-title":"Differential expression of mucosal trefoil factors and mucins in pediatric inflammatory bowel diseases","volume":"4","author":"Hensel","year":"2014","journal-title":"Sci Rep"},{"key":"2026013010481755300_izaf293-B44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.15403\/jgld-250","article-title":"Elevated colonic mucin expression correlates with extended time to surgery for ulcerative colitis patients","volume":"28","author":"Eshelman","year":"2019","journal-title":"J Gastrointestin Liver Dis."},{"key":"2026013010481755300_izaf293-B45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000522039","article-title":"Oral corticosteroids impair mucin production and alter the posttransplantation microbiota in the gut","volume":"103","author":"Okafuji","year":"2022","journal-title":"Digestion"},{"key":"2026013010481755300_izaf293-B46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00054725-199902000-00004","article-title":"Abnormalities in mucin gene expression in Crohn\u02bcs disease","volume":"5","author":"Buisine","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1098-2825(1998)12:3<150::AID-JCLA4>3.0.CO;2-D","article-title":"Immunohistochemical detection of MUC2 mucin core protein in ulcerative colitis","volume":"12","author":"Hinoda","year":"1998","journal-title":"J Clin Lab Anal"},{"key":"2026013010481755300_izaf293-B48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gut.49.4.544","article-title":"Mucin gene expression in intestinal epithelial cells in Crohn\u2019s disease","volume":"49","author":"Buisine","year":"2001","journal-title":"Gut"},{"key":"2026013010481755300_izaf293-B49","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1369\/jhc.5A6904.2006","article-title":"Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis","volume":"54","author":"Longman","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"2026013010481755300_izaf293-B50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/path.5258","article-title":"Ulcer-associated cell lineage expresses genes involved in regeneration and is hallmarked by high neutrophil gelatinase-associated lipocalin (NGAL) levels","volume":"248","author":"Thorsvik","year":"2019","journal-title":"J Pathol"},{"key":"2026013010481755300_izaf293-B51","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjv223","article-title":"Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis","volume":"10","author":"Alipour","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2026013010481755300_izaf293-B52","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2147\/JIR.S410057","article-title":"A novel nomogram combining mucus barrier index for predicting treatment failures in ulcerative colitis","volume":"16","author":"Wang","year":"2023","journal-title":"J Inflamm Res"},{"key":"2026013010481755300_izaf293-B53","first-page":"488","article-title":"Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children","volume":"38","author":"Shaoul","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2026013010481755300_izaf293-B54","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ijbiomac.2020.07.191","article-title":"The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression","volume":"164","author":"Liu","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2026013010481755300_izaf293-B55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.44.3.387","article-title":"Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis","volume":"44","author":"Van Klinken","year":"1999","journal-title":"Gut"},{"key":"2026013010481755300_izaf293-B56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jss.2023.08.027","article-title":"Disease severity impairs generation of intestinal organoid cultures from inflammatory bowel disease patients","volume":"293","author":"Ding","year":"2024","journal-title":"J Surg Res."},{"key":"2026013010481755300_izaf293-B57","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1097\/MIB.0000000000000523","article-title":"Aberrant niche signaling in the etiopathogenesis of ulcerative colitis","volume":"21","author":"Kini","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B58","doi-asserted-by":"crossref","first-page":"152115","DOI":"10.1016\/j.acthis.2023.152115","article-title":"Association between neuropeptides and mucins in Crohn\u2019s disease mucous cells","volume":"125","author":"Miller","year":"2023","journal-title":"Acta Histochem."},{"key":"2026013010481755300_izaf293-B59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","article-title":"Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis","volume":"63","author":"Johansson","year":"2014","journal-title":"Gut"},{"key":"2026013010481755300_izaf293-B60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2006.04.020","article-title":"Muc2-deficient mice spontaneously develop colitis, indicating that muc2 is critical for colonic protection","volume":"131","author":"Van der Sluis","year":"2006","journal-title":"Gastroenterology"},{"key":"2026013010481755300_izaf293-B61","doi-asserted-by":"publisher","first-page":"e29094","DOI":"10.1371\/journal.pone.0029094","article-title":"MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients","volume":"6","author":"Capuano","year":"2011","journal-title":"PLoS One"},{"key":"2026013010481755300_izaf293-B62","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1038\/s41598-017-04952-7","article-title":"Mucin 2 silencing promotes colon cancer metastasis through interleukin-6 signaling","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci Rep."},{"key":"2026013010481755300_izaf293-B63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/BF00702345","article-title":"Colonic mucins in ulcerative colitis: evidence for loss of sulfation","volume":"13","author":"Corfield","year":"1996","journal-title":"Glycoconj J"},{"key":"2026013010481755300_izaf293-B64","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/ibd.21625","article-title":"Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation","volume":"17","author":"Larsson","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B65","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12967-023-04687-2","article-title":"Muc2 mucin o-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway","volume":"21","author":"Wei","year":"2023","journal-title":"J Transl Med."},{"key":"2026013010481755300_izaf293-B66","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jmg.36.11.859","article-title":"Ulcerative colitis is not associated with differences in MUC2 mucin allele length","volume":"36","author":"Swallow","year":"1999","journal-title":"J Med Genet"},{"key":"2026013010481755300_izaf293-B67","doi-asserted-by":"publisher","first-page":"e0159609","DOI":"10.1371\/journal.pone.0159609","article-title":"Pooled resequencing of 122 ulcerative colitis genes in a large Dutch cohort suggests population-specific associations of rare variants in Muc2","volume":"11","author":"Visschedijk","year":"2016","journal-title":"PLoS One."},{"key":"2026013010481755300_izaf293-B68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/ibd\/izaa075","article-title":"Transcriptional signatures that define ulcerative colitis in remission","volume":"27","author":"Fenton","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.crohns.2007.06.006","article-title":"Aberrant gastric apomucin expression in ulcerative colitis and associated neoplasia","volume":"1","author":"Borralho","year":"2007","journal-title":"J Crohns Colitis"},{"key":"2026013010481755300_izaf293-B70","doi-asserted-by":"crossref","first-page":"304894","DOI":"10.1155\/2013\/304894","article-title":"Colon mucosa exhibits loss of ectopic MUC5AC expression in patients with ulcerative colitis treated with oral tacrolimus","volume":"2013","author":"Mizoshita","year":"2013","journal-title":"ISRN Gastroenterol"},{"key":"2026013010481755300_izaf293-B71","doi-asserted-by":"publisher","first-page":"687257","DOI":"10.1155\/2014\/687257","article-title":"Adalimumab treatment in biologically na\u00efve Crohn\u2019s disease: relationship with ectopic MUC5AC expression and endoscopic improvement","volume":"2014","author":"Mizoshita","year":"2014","journal-title":"Gastroenterol Res Pract."},{"key":"2026013010481755300_izaf293-B72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","article-title":"Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance","volume":"19","author":"Pothuraju","year":"2020","journal-title":"Mol Cancer."},{"key":"2026013010481755300_izaf293-B73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-4598-5-10","article-title":"Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium","volume":"5","author":"Babu","year":"2006","journal-title":"Mol Cancer."},{"key":"2026013010481755300_izaf293-B74","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.3390\/ijms25031858","article-title":"Mucin expression profiles in ulcerative colitis: new insights on the histological mucosal healing","volume":"25","author":"Leoncini","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026013010481755300_izaf293-B75","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1701632","article-title":"Airway mucin concentration as a marker of chronic bronchitis","volume":"377","author":"Mehmet","year":"2025","journal-title":"New Engl J Med"},{"key":"2026013010481755300_izaf293-B76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ibd.21074","article-title":"Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease","volume":"16","author":"Phillips","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"2026013010481755300_izaf293-B77","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/ibd.21651","article-title":"Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn\u02bcs disease and ulcerative colitis","volume":"17","author":"Umeno","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B78","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/MIB.0b013e318281f454","article-title":"Genome-wide association study signal at the 12q12 locus for Crohn\u2019s disease may represent associations with the MUC19 gene","volume":"19","author":"Kumar","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B79","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng.952","article-title":"Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease","volume":"43","author":"Rivas","year":"2011","journal-title":"Nat Genet."},{"key":"2026013010481755300_izaf293-B80","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/bioinformatics\/btw125","article-title":"Haplotype synthesis analysis reveals functional variants underlying known genome-wide associated susceptibility loci","volume":"32","author":"Lacour","year":"2016","journal-title":"Bioinformatics."},{"key":"2026013010481755300_izaf293-B81","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12916-023-02878-8","article-title":"Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn\u2019s disease: a multi-omics Mendelian randomization study","volume":"21","author":"Xu","year":"2023","journal-title":"BMC Med."},{"key":"2026013010481755300_izaf293-B82","doi-asserted-by":"publisher","first-page":"9771","DOI":"10.1038\/s41598-021-89087-6","article-title":"Intestinal mucosa-derived DNA methylation signatures in the penetrating intestinal mucosal lesions of Crohn\u2019s disease","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep."},{"key":"2026013010481755300_izaf293-B83","doi-asserted-by":"publisher","first-page":"e0311495","DOI":"10.1371\/journal.pone.0311495","article-title":"Identification of O-glycosylation related genes and subtypes in ulcerative colitis based on machine learning","volume":"19","author":"Lu","year":"2024","journal-title":"PLoS One"},{"key":"2026013010481755300_izaf293-B84","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/0118715303263609231101074056","article-title":"Identification of diagnosis and typological characteristics associated with ferroptosis for ulcerative colitis via bioinformatics and machine learning","volume":"24","author":"Wang","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"2026013010481755300_izaf293-B85","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/iid3.506","article-title":"Machine learning gene expression predicting model for ustekinumab response in patients with Crohn\u2019s disease","volume":"9","author":"He","year":"2021","journal-title":"Immun Inflamm Dis."},{"key":"2026013010481755300_izaf293-B86","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.34355","article-title":"Interleukin-22 and interleukin-22\u2013producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis","volume":"64","author":"Ciccia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026013010481755300_izaf293-B87","doi-asserted-by":"publisher","first-page":"3000605211042975","DOI":"10.1177\/03000605211042975","article-title":"Integrative analysis of ferroptosis-related genes in ulcerative colitis","volume":"49","author":"Cui","year":"2021","journal-title":"J Int Med Res."},{"key":"2026013010481755300_izaf293-B88","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/ibd.21208","article-title":"NOD2 status and human ileal gene expression","volume":"16","author":"Hamm","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"2026013010481755300_izaf293-B89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15403\/jgld-576","article-title":"Molecular signature of persistent histological inflammation in ulcerative colitis with mucosal healing","volume":"29","author":"Manuc","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"2026013010481755300_izaf293-B90","doi-asserted-by":"crossref","first-page":"1401733","DOI":"10.3389\/fimmu.2024.1401733","article-title":"Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn\u2019s disease","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol."},{"key":"2026013010481755300_izaf293-B91","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/cells9081793","article-title":"Molecular changes in the non-inflamed terminal ileum of patients with ulcerative colitis","volume":"9","author":"Lee","year":"2020","journal-title":"Cells"},{"key":"2026013010481755300_izaf293-B92","first-page":"1731","article-title":"Mucin-1 expression and localization in epithelial cells shows characteristic and distinct patterns in inflammatory bowel diseases and colorectal cancer","volume":"12","author":"Khemiri","year":"2019","journal-title":"Int J Clin Exp Pathol"},{"key":"2026013010481755300_izaf293-B93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2350\/08-06-0479.1","article-title":"Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease","volume":"13","author":"Furr","year":"2010","journal-title":"Pediatr Dev Pathol."},{"key":"2026013010481755300_izaf293-B94","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MCG.0000000000001340","article-title":"Altered expression of the epithelial mucin MUC1 accompanies endoscopic recurrence of postoperative Crohn\u2019s disease","volume":"55","author":"Hashash","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"2026013010481755300_izaf293-B95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"2026013010481755300_izaf293-B96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-2478(93)90086-H","article-title":"Detection of a circulating antibody against a peptide epitope on a mucin core protein, MUC1, in ulcerative colitis","volume":"35","author":"Hinoda","year":"1993","journal-title":"Immunol Lett"},{"key":"2026013010481755300_izaf293-B97","doi-asserted-by":"crossref","first-page":"105284","DOI":"10.18632\/oncotarget.22168","article-title":"Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-\u03baB p65 and EzH2, in colitis-associated cancer","volume":"8","author":"Cascio","year":"2017","journal-title":"Oncotarget"},{"key":"2026013010481755300_izaf293-B98","first-page":"671","article-title":"Genetic variants of mucins: unexplored conundrum","volume":"38","author":"Kumar","year":"2017","journal-title":"Carcinogenesis"},{"key":"2026013010481755300_izaf293-B99","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41698-025-01016-2","article-title":"Mucin-1: a promising pan-cancer therapeutic target","volume":"9","author":"Grewal","year":"2025","journal-title":"NPJ Precis Oncol."},{"key":"2026013010481755300_izaf293-B100","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/carcin\/bgaa082","article-title":"MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment","volume":"41","author":"Kufe","year":"2020","journal-title":"Carcinogenesis"},{"key":"2026013010481755300_izaf293-B101","doi-asserted-by":"crossref","first-page":"659018","DOI":"10.1155\/2015\/659018","article-title":"Differential expression of MUC12, MUC16, and MUC20 in patients with active and remission ulcerative colitis","volume":"2015","author":"Yamamoto-Furusho","year":"2015","journal-title":"Mediators Inflamm."},{"key":"2026013010481755300_izaf293-B102","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/ijc.25256","article-title":"MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer","volume":"127","author":"Matsuyama","year":"2010","journal-title":"Int J Cancer"},{"key":"2026013010481755300_izaf293-B103","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1515\/cclm-2018-0139","article-title":"Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases","volume":"56","author":"Filippou","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2026013010481755300_izaf293-B104","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s00535-013-0885-z","article-title":"Functions and regulation of MUC13 mucin in colon cancer cells","volume":"49","author":"Gupta","year":"2014","journal-title":"J Gastroenterol"},{"key":"2026013010481755300_izaf293-B105","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/onc.2016.241","article-title":"MUC13 protects colorectal cancer cells from death by activating the NF-\u03baB pathway and is a potential therapeutic target","volume":"36","author":"Sheng","year":"2017","journal-title":"Oncogene"},{"key":"2026013010481755300_izaf293-B106","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12885-025-13461-0","article-title":"The role of MUC16 in tumor biology and tumor immunology in ovarian cancer","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cancer"},{"key":"2026013010481755300_izaf293-B107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2018.01.017","article-title":"MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer","volume":"418","author":"Fan","year":"2018","journal-title":"Cancer Lett"},{"key":"2026013010481755300_izaf293-B108","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jcp.2010.078717","article-title":"Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon","volume":"63","author":"Senapati","year":"2010","journal-title":"J Clin Pathol"},{"key":"2026013010481755300_izaf293-B109","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s10120-019-00932-0","article-title":"Epigenetic downregulation of MUC17 by H. pylori infection facilitates NF-\u03baB-mediated expression of CEACAM1-3S in human gastric cancer","volume":"22","author":"Lin","year":"2019","journal-title":"Gastric Cancer"},{"key":"2026013010481755300_izaf293-B110","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1165\/rcmb.2006-0110OC","article-title":"Functional analysis of human MUC7 mucin gene 5\u2032-flanking region in lung epithelial cells","volume":"35","author":"Li","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026013010481755300_izaf293-B111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jcm7020026","article-title":"Effect of MUC8 on airway inflammation: a friend or a foe?","volume":"7","author":"Cha","year":"2018","journal-title":"J Clin Med."},{"key":"2026013010481755300_izaf293-B112","doi-asserted-by":"crossref","first-page":"E601","DOI":"10.1002\/ibd.21920","article-title":"Reduced expression of mucin 9 (MUC9) in patients with ulcerative colitis","volume":"18","author":"Yamamoto-Furusho","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2026013010481755300_izaf293-B113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.MIB.0000194181.46930.88","article-title":"Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease","volume":"12","author":"Bardin","year":"2006","journal-title":"Inflamm Bowel Dis."},{"key":"2026013010481755300_izaf293-B114","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.ajpath.2012.11.005","article-title":"A novel function of MUC18: amplification of lung inflammation during bacterial infection","volume":"182","author":"Wu","year":"2013","journal-title":"Am J Pathol"},{"key":"2026013010481755300_izaf293-B115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-1119(01)00736-3","article-title":"Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression","volume":"279","author":"Wu","year":"2001","journal-title":"Gene"},{"key":"2026013010481755300_izaf293-B116","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40543-025-00489-x","article-title":"Proteomic characterization and bioinformatic insights into MUC18 function in gastric cancer","volume":"16","author":"Kim","year":"2025","journal-title":"J Anal Sci Technol."},{"key":"2026013010481755300_izaf293-B117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1479-5876-11-151","article-title":"Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer","volume":"11","author":"Xiao","year":"2013","journal-title":"J Transl Med."},{"key":"2026013010481755300_izaf293-B118","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2015.11.025","article-title":"MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin \u03b21 pathway","volume":"140","author":"Chen","year":"2016","journal-title":"Gynecol Oncol."},{"key":"2026013010481755300_izaf293-B119","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1038\/s41388-018-0403-0","article-title":"Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF\/MET pathway","volume":"37","author":"Chen","year":"2018","journal-title":"Oncogene"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/2\/375\/65492248\/izaf293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/2\/375\/65492248\/izaf293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T15:48:32Z","timestamp":1769788112000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/2\/375\/8341535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":119,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf293","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,24]]}}}